Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Pharmaceuticals Europe News Breaking News: Europe
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Politics Breaking News: Politics Europe Economy
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags LILLY DRN Pharmaceuticals Drug Retail
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags LILLY DRN CVS Health Corp Healthy Returns
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Biotech and Pharmaceuticals Roche Holding AG Pharmaceuticals
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Make It Make It / Money Hims & Hers Health Inc
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Enterprise Novo Nordisk A/S Technology
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags LILLY DRN Affirm Holdings Inc Starbucks Corp
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Amgen Inc Pharmaceuticals Pfizer Inc
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags CVS Health Corp US: News Pharmaceuticals
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Biotech and Pharmaceuticals Business News Business
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags LILLY DRN Biotech and Pharmaceuticals Social issues
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Novo Nordisk A/S Pfizer Inc Biotech and Pharmaceuticals
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Shell PLC Europe Markets Earnings
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Structure Therapeutics Inc LILLY DRN AstraZeneca PLC
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags UBS Group AG Asia Markets World Markets
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Health care industry Companies Health & Science
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Business News Politics Novo Nordisk A/S
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Business News Biotechnology Business
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Policy U/S/ Economy AstraZeneca PLC
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Trade Novo Nordisk A/S Biotechnology
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags LILLY DRN Biotech and Pharmaceuticals Business News
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Novo Nordisk A/S Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Tesla Inc Market Outlook World Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Market Outlook Asia Markets Tesla Inc
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Social issues Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags LVMH Moet Hennessy Louis Vuitton SE Markets Novo Nordisk A/S
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags LILLY DRN Structure Therapeutics Inc AstraZeneca PLC
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Novo Nordisk A/S Biotechnology Business
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.